Reference data : LOINC code

Filter

Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType		Clear filter
AND
Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType
AND
Filter on:		In :	All (9) Loinc Number Component Property System Time aspect Long Common name Relat_nms MethodType ScaleType

Results

104,672 results found

• First page
• Previous page
• /4187
• Next page
• Last page

Loinc Number	Component	Property	System	Time aspect	ScaleType	MethodType	Relat_nms	loincStatus	Long Common name	answerList	chngType	DefinitionDescription	dtLastCh	exactCmspy	exampleUnits	exmplAnswers	externalCopyrightNotice	formula	hl7FieldSubfieldId	InpcPercentage	ipccUnits	loincClass	loincFinal	loincNum	mapTo	methodTyp	molarMass	naaccrId	orderObs	panelElements	reference	scope	setRoot	shortName	source	surveyQuestSrc	surveyQuestText	unitsRequired	acssym	relatedNames2	VersionLastChanged	VersionFirstRelease	ValidHL7AttachmentRequest	PanelType	AssociatedObservations	EXTERNAL_COPYRIGHT_LINK	HL7_ATTACHMENT_STRUCTURE	CONSUMER_NAME	EXAMPLE_UCUM_UNITS	STATUS_REASON	STATUS_TEXT	CHANGE_REASON_PUBLIC	COMMON_TEST_RANK	COMMON_ORDER_RANK
47154-0	Lead^post EDTA therapy	SCnc	Urine	Pt	Qn			ACTIVE	Lead [Moles/volume] in Urine --post EDTA therapy		MIN	DefinitionDescription			umol/L							CHAL		47154-0					Observation				0	Lead p EDTA Ur-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; p EDTA; Painter's colic; PB; Plumbism; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration; UA; UR; Urn	2.7	2.19								umol/L				0
47155-7	Norepinephrine^10M post standing	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --10 minutes post standing		MIN	DefinitionDescription			nmol/L							CHAL		47155-7					Observation				0	Norepineph 10M p Sta Plas-sCnc				N		10M p Sta; After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Stand); Substance Concentration; WB; Weight bearing	2.7	2.19								nmol/L				0
47156-5	Norepinephrine^1H post 300 ug clonidine PO	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --1 hour post 300 ug cloNIDine PO		MIN	DefinitionDescription			nmol/L							CHAL		47156-5					Observation				0	Norepineph 1h p 300 ug CLN PO Plas-sCnc				N		1 hour; 1.0Hr; 1h p 300 ug CLN PO; 60 min; 60 minutes; 60M; 60min; After; Catapres; CHEMISTRY.CHALLENGE TESTING; Level; mcg; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	2.7	2.19								nmol/L				0
47157-3	Norepinephrine^1H post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --1 hour post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47157-3					Observation				0	Norepineph 1h p chal Plas-sCnc				N		1 hour; 1.0Hr; 1h p chal; 60 min; 60 minutes; 60M; 60min; After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	2.7	2.19								nmol/L				0
47158-1	Norepinephrine^2H post 300 ug clonidine PO	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --2 hours post 300 ug cloNIDine PO		MIN	DefinitionDescription			nmol/L							CHAL		47158-1					Observation				0	Norepineph 2h p 300 ug CLN PO Plas-sCnc				N		120 min; 120 minutes; 120min; 2 hours; 2h p 300 ug CLN PO; After; Catapres; CHEMISTRY.CHALLENGE TESTING; Level; mcg; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	2.7	2.19								nmol/L				0
47159-9	Norepinephrine^2H post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --2 hours post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47159-9					Observation				0	Norepineph 2h p chal Plas-sCnc				N		120 min; 120 minutes; 120min; 2 hours; 2h p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	2.7	2.19								nmol/L				0
4716-7	HLA-A11	PrThr	Bld/Tiss	Pt	Ord			ACTIVE	HLA-A11 [Presence]		MIN	DefinitionDescription										HLA		4716-7					Observation				0	HLA-A11 Ql						Blood; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.56	1											This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld' to 'Bld/Tiss' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
47160-7	Norepinephrine^2nd specimen post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --2nd specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47160-7					Observation				0	Norepineph sp2 p chal Plas-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Convalescent; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; sp2; sp2 p chal; Spec; Substance concentration	2.7	2.19								nmol/L				0
47161-5	Norepinephrine^2nd specimen post XXX challenge	SCnc	Urine	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Urine --2nd specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47161-5					Observation				0	Norepineph sp2 p chal Ur-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Convalescent; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Point in time; Post immunization; PST; QNT; Quan; Quant; Quantitative; Random; Second; sp2; sp2 p chal; Spec; Substance concentration; UA; UR; Urn	2.7	2.19								nmol/L				0
47162-3	Norepinephrine^3H post 300 ug clonidine PO	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --3 hours post 300 ug cloNIDine PO		MIN	DefinitionDescription			nmol/L							CHAL		47162-3					Observation				0	Norepineph 3h p 300 ug CLN PO Plas-sCnc				N		3h p 300 ug CLN PO; After; Catapres; CHEMISTRY.CHALLENGE TESTING; Level; mcg; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	2.7	2.19								nmol/L				0
47163-1	Norepinephrine^3H post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --3 hours post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47163-1					Observation				0	Norepineph 3h p chal Plas-sCnc				N		3h p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	2.7	2.19								nmol/L				0
47164-9	Norepinephrine^3rd specimen post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --3rd specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47164-9					Observation				0	Norepineph sp3 p chal Plas-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp3; sp3 p chal; Spec; Substance concentration	2.7	2.19								nmol/L				0
47165-6	Norepinephrine^3rd specimen post XXX challenge	SCnc	Urine	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Urine --3rd specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47165-6					Observation				0	Norepineph sp3 p chal Ur-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp3; sp3 p chal; Spec; Substance concentration; UA; UR; Urn	2.7	2.19								nmol/L				0
47166-4	Norepinephrine^4H post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --4 hours post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47166-4					Observation				0	Norepineph 4h p chal Plas-sCnc				N		4h p chal; After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; Substance concentration	2.7	2.19								nmol/L				0
47167-2	Norepinephrine^4th specimen post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --4th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47167-2					Observation				0	Norepineph sp4 p chal Plas-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp4; sp4 p chal; Spec; Substance concentration	2.7	2.19								nmol/L				0
47168-0	Norepinephrine^4th specimen post XXX challenge	SCnc	Urine	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Urine --4th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47168-0					Observation				0	Norepineph sp4 p chal Ur-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp4; sp4 p chal; Spec; Substance concentration; UA; UR; Urn	2.7	2.19								nmol/L				0
47169-8	Norepinephrine^5th specimen post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --5th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47169-8					Observation				0	Norepineph sp5 p chal Plas-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp5; sp5 p chal; Spec; Substance concentration	2.7	2.19								nmol/L				0
4717-5	HLA-A1	PrThr	Bld/Tiss^Donor	Pt	Ord			ACTIVE	HLA-A1 [Presence] in Donor		MAJ	DefinitionDescription										HLA		4717-5					Observation				0	HLA-A1 Donr Ql						Blood; Donr; Genetics; Heredity; Heritable; HLA ANTIGEN; Human Leukocyte Antigen; Inherited; Ordinal; Point in time; PR; QL; Qual; Qualitative; Random; Screen; Tissue; Tissue, unspecified; WB; Whole blood; Whole blood or Tissue	2.56	1											This test is commonly performed on cells found in saliva and buccal swabs as well as blood specimens. Changed specimen from 'Bld^donor' to 'Bld/Tiss^donor' to represent both specimen types.; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016.	0
47170-6	Norepinephrine^5th specimen post XXX challenge	SCnc	Urine	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Urine --5th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47170-6					Observation				0	Norepineph sp5 p chal Ur-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp5; sp5 p chal; Spec; Substance concentration; UA; UR; Urn	2.7	2.19								nmol/L				0
47171-4	Norepinephrine^6th specimen post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --6th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47171-4					Observation				0	Norepineph sp6 p chal Plas-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp6; sp6 p chal; Spec; Substance concentration	2.7	2.19								nmol/L				0
47172-2	Norepinephrine^6th specimen post XXX challenge	SCnc	Urine	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Urine --6th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47172-2					Observation				0	Norepineph sp6 p chal Ur-sCnc				N		After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp6; sp6 p chal; Spec; Substance concentration; UA; UR; Urn	2.7	2.19								nmol/L				0
47173-0	Catecholamines^7th specimen post XXX challenge	SCnc	Plas	Pt	Qn			ACTIVE	Catecholamines [Moles/volume] in Plasma --7th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47173-0					Observation				0	Catechols sp7 p chal Plas-sCnc				N		^7th spec pst XXX chal; After; Cate; Catec; Catech; Catechol; Catecholamine; Catecholamines.total; Catechols; CHEMISTRY.CHALLENGE TESTING; Epinephrine+norepinephrine+dopamine; Level; p chal; Pl; Plasma; Plsm; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp7; sp7 p chal; Spec; Substance concentration	2.7	2.19								nmol/L				0
47174-8	Norepinephrine^7th specimen post XXX challenge	SCnc	Urine	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Urine --7th specimen post XXX challenge		MIN	DefinitionDescription			nmol/L							CHAL		47174-8					Observation				0	Norepineph sp7 p chal Ur-sCnc				N		^7th spec pst XXX chal; After; CHEMISTRY.CHALLENGE TESTING; Level; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; p chal; Point in time; PST; QNT; Quan; Quant; Quantitative; Random; sp7; sp7 p chal; Spec; Substance concentration; UA; UR; Urn	2.7	2.19								nmol/L				0
47175-5	Norepinephrine^pre 300 ug clonidine PO	SCnc	Plas	Pt	Qn			ACTIVE	Norepinephrine [Moles/volume] in Plasma --pre 300 ug cloNIDine PO		MIN	DefinitionDescription			nmol/L							CHAL		47175-5					Observation				0	Norepineph pre 300 ug CLN PO Plas-sCnc				N		Before; Catapres; CHEMISTRY.CHALLENGE TESTING; Level; mcg; NE; Noradrenalin; Norepi; Norepin; Norepineph; Norepinephr; Noreppi; Pl; Plasma; Plsm; Point in time; pre 300 ug CLN PO; QNT; Quan; Quant; Quantitative; Random; Substance concentration	2.7	2.19								nmol/L				0
47176-3	Parathyrin.intact^10M post excision	SCnc	Ser/Plas	Pt	Qn			ACTIVE	Parathyrin.intact [Moles/volume] in Serum or Plasma --10 minutes post excision		MIN	DefinitionDescription			pmol/L							CHAL		47176-3					Observation				0	PTH-Intact 10m p Excision SerPl-sCnc				N		10m p Excision; After; CHEMISTRY.CHALLENGE TESTING; Intact Parathormone; intact parathyroid hormone; iPTH; Level; p Excision; Parathormone; Parathyroid hormone; Pl; Plasma; Plsm; Point in time; post surgery; PST; PTH; PTH-Intact; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tumor marker	2.7	2.19								pmol/L				0

104,672 results found

• First page
• Previous page
• /4187
• Next page
• Last page